Gregory Bowles
Director Ejecutivo en Aquyre Biosciences, Inc. .
Perfil
Gregory Bowles is the founder of FlexDex, Inc. He is currently the President, Chief Executive Officer & Director at Aquyre Biosciences, Inc. He has previously worked as a Sales Representative at Johnson & Johnson, Sales Manager-Michigan Area at Intuitive Surgical, Inc., Vice President-Sales at EndoGastric Solutions, Inc., and Cryptologist at United States Navy (District of Columbia).
He completed his undergraduate degree at Northwood University (Michigan).
Cargos activos de Gregory Bowles
Empresas | Cargo | Inicio |
---|---|---|
Aquyre Biosciences, Inc.
Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Director Ejecutivo | 05/12/2023 |
Antiguos cargos conocidos de Gregory Bowles.
Empresas | Cargo | Fin |
---|---|---|
FlexDex, Inc.
FlexDex, Inc. Medical SpecialtiesHealth Technology FlexDex, Inc. engages in the provision of robotic surgery. It engages in research of parallel kinematics, virtual center of rotation, and flexure mechanisms at the school’s precision systems design lab. The firm enhances the capabilities of all MIS instruments and endoscopes. The company was founded by James D. Geiger, Shorya Awtar and Gregory Bowles and is headquartered in Brighton, MI. | Fundador | 01/01/2020 |
United States Navy (District of Columbia) | Corporate Officer/Principal | - |
JOHNSON & JOHNSON | Ventas & Marketing | - |
INTUITIVE SURGICAL, INC. | Ventas & Marketing | - |
EndoGastric Solutions, Inc.
EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA. | Ventas & Marketing | - |
Formación de Gregory Bowles.
Northwood University (Michigan) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
JOHNSON & JOHNSON | Health Technology |
INTUITIVE SURGICAL, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
EndoGastric Solutions, Inc.
EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA. | Health Technology |
United States Navy (District of Columbia) | Government |
FlexDex, Inc.
FlexDex, Inc. Medical SpecialtiesHealth Technology FlexDex, Inc. engages in the provision of robotic surgery. It engages in research of parallel kinematics, virtual center of rotation, and flexure mechanisms at the school’s precision systems design lab. The firm enhances the capabilities of all MIS instruments and endoscopes. The company was founded by James D. Geiger, Shorya Awtar and Gregory Bowles and is headquartered in Brighton, MI. | Health Technology |
Aquyre Biosciences, Inc.
Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Health Services |
- Bolsa de valores
- Insiders
- Gregory Bowles